Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Quigley, David A., Dang, Ha X., Zhao, Shuang G., Lloyd, Paul, Aggarwal, Rahul, Alumkal, Joshi J., Foye, Adam, Kothari, Vishal +55 more·2018·Cell

DOI 10.1016/j.cell.2018.06.039

Cited by (738)

Items 301–400 of 738

Clinical implications of homologous recombination repair mutations in prostate cancer
Pablo Cresta Morgado, Joaquı́n Mateo · 2022 · The Prostate
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies
Amado J. Zurita, Ryon P. Graf, Guillermo Javierre Villacampa, Kira Raskina, Ethan S. Sokol, Dexter X. Jin, Emmanuel S. Antonarakis, Gerald Li, Richard S.P. Huang, Irene Casanova‐Salas et al. · 2022 · JCO Precision Oncology
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning
Anouk C. de Jong, Alexandra Danyi, Job van Riet, Ronald de Wit, Martin Sjöström, Felix Yi-Chung Feng, Jeroen de Ridder, Martijn P. Lolkema · 2023 · Nature Communications
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
Irene Zamora, Michael R. Freeman, Ignacio Encı́o, Mirja Rotinen · 2023 · International Journal of Molecular Sciences
CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer
Ke-Qi Lu, Zuo‐Lin Li, Qian Zhang, Qing Yin, Yilin Zhang, Wei‐Jie Ni, LiangYun-Zi Jiang, Wei He, Bin Wang · 2024 · Scientific Reports
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
Marina Nasrin Sharifi, Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, Viridiana Carreno, Katherine R. Kaufmann, Alex Hong Chang, Luke A. Nunamaker, Charlotte Linebarger et al. · 2025 · Cancer Discovery
Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression via Up-Regulation of MicroRNA-195-5p
Pingbo Xie, Mingsheng Liu, Fen Chen, Shaomei Wu, Tao Shao, Wei Ting Wang, Chenxiang Xu, Hongqing Zhou · 2020 · Frontiers in Genetics
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases
Tesa Severson, Yanyun Zhu, Angelo Michael De Marzo, Tracy Jones, Jonathan W. Simons, William G. Nelson, Srinivasan Yegnasubramanian, Matthew L. Freedman, Lodewyk F.A. Wessels, Andries Marinus Bergman et al. · 2021 · Molecular Oncology
Identifying the role of apolipoprotein A-I in prostate cancer
Jing Wang, Lingfan Xu, Cheng Liu, Tao Huang, Chao-Zhao Liang, Yidong Fan · 2021 · Asian Journal of Andrology
Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models
Weiping Li, Michael M. Shen · 2021 · Seminars in Cancer Biology
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
Sander A. L. Palit, Jeroen van Dorp, Daniël J. Vis, Cor Lieftink, Simon Linder, Roderick L. Beijersbergen, Andries Marinus Bergman, Wilbert T. Zwart, Michiel S. van der Heijden · 2021 · Scientific Reports
Molecular Pathology of Prostate Cancer
İbrahim Kulaç, Martine P. Roudier, Michael C. Haffner · 2024 · Clinics in Laboratory Medicine
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer
Kei Mizuno, Sheng‐Yu Ku, Varadha Balaji Venkadakrishnan, Martin K. Bakht, Michael Sigouros, Joanna Chan, Anna Trigos, Jordan H. Driskill, Jyothi Manohar, Abigail S. King et al. · 2025 · Nature Communications
Perspectives on Circular RNAs as Prostate Cancer Biomarkers
Jiajie Fang, Jianfei Qi, Xuesen Dong, Jindan Luo · 2020 · Frontiers in Cell and Developmental Biology
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer
Harsimar B. Kaur, Thiago Vidotto, Adrianna Amaral de Aragao Mendes, Daniela Correia Salles, William B. Isaacs, Emmanuel S. Antonarakis, Tamara Levin Lotan · 2021 · Cancer Immunology Immunotherapy
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
Vincenza Conteduca, Chiara Casadei, Emanuela Scarpi, Nicole Brighi, Giuseppe Schepisi, Cristian Lolli, Giorgia Gurioli, Ilaria Toma, Giulia Poti, Alberto Farolfi et al. · 2022 · Cancers
Review of prostate cancer genomic studies in Africa
Chaimae Samtal, Islam El Jaddaoui, Salsabil Hamdi, Laila Bouguenouch, Karim Ouldim, Chakib Nejjari, Hassan Ghazal, Hicham Bekkari · 2022 · Frontiers in Genetics
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
Shaham Beg, Rohan Bareja, Kentaro Ohara, Kenneth Eng, David C. Wilkes, David J. Pisapia, Wael Al Zoughbi, Sarah Kudman, Wei Zhang, Rema A. Rao et al. · 2020 · Translational Oncology
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1
James E. Melnyk, Veronica Steri, Hao Gia Nguyen, Yeonjoo C Hwang, John Dozier Gordan, Byron C. Hann, Felix Yi-Chung Feng, Kevan M. Shokat · 2022 · Oncogene
Molecular Pathology of Prostate Cancer
İbrahim Kulaç, Martine P. Roudier, Michael C. Haffner · 2021 · Surgical pathology clinics
Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects
Pedro Isaacsson Velho, Diogo Assed Bastos, Pedro Tofani Saint’ana, Brenda Rigatti, Emily Tonin da Costa, David Queiroz Borges Muniz, Felipe Andreis, Rafael Dal Ponte Ferreira, Luana Giongo Pedrotti, Simone Maistro et al. · 2024 · Clinical Cancer Research
Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
Tesa Severson, Xintao Qiu, Mohammed Alshalalfa, Martin Sjöström, David Alan Quigley, Andries Marinus Bergman, Henry W. Long, Felix Yi-Chung Feng, Matthew L. Freedman, Wilbert T. Zwart et al. · 2022 · Clinical Epigenetics
The role of glutamine metabolism in castration-resistant prostate cancer
Bing Qiang Zhao, Jing Wang, Li Chen, Hong Wang, Chao-Zhao Liang, Jiaoti Huang, Lingfan Xu · 2023 · Asian Journal of Andrology
Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications
Margo Brooke Gerke, Caroline Stewart Jansen, Mehmet Asım Bilen · 2024 · Cancers
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment
Carly D. Miller, Pornlada Likasitwatanakul, Eamon Toye, Justin H. Hwang, Emmanuel S. Antonarakis · 2024 · Expert Review of Anticancer Therapy
Plasma Cell–Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer
Joonatan Sipola, Aslı D. Munzur, Edmond M. Kwan, Clara C. Y. Seo, Benjamin J. Hauk, Karan Parekh, Yi Jou Liao, Cecily Q. Bernales, Gráinne Donnellan, Ingrid Bloise et al. · 2024 · Cancer Research
Integrated analysis of optical mapping and whole-genome sequencing reveals intratumoral genetic heterogeneity in metastatic lung squamous cell carcinoma
Yizhou Peng, Chongze Yuan, Xiaoting Tao, Yue Zhao, Xingxin Yao, Lingdun Zhuge, Jianwei Huang, Qiang Zheng, Yue Zhang, Hui Hong et al. · 2020 · Translational Lung Cancer Research
Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations
Roni Rasnic, Nathan Linial, Michal Linial · 2020 · Scientific Reports
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy
Wentao Chen, Kurt Yun Mou, Paige E. Solomon, Rahul Raj Aggarwal, Kevin Leung, James A. Wells · 2021 · Proceedings of the National Academy of Sciences
Identification and characterization of inheritable structural variations induced by ion beam radiations in rice
Yunchao Zheng, Shan Li, Jianzhong Huang, Hao-Wei Fu, Libin Zhou, Yoshiya Furusawa, Qingyao Shu · 2021 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors
David Johnson Einstein, Seiji Arai, Carla Calagua, Fang Xie, Olga S. Voznesensky, Brian J. Capaldo, Christina I. Luffman, Jonathan L. Hecht, Steven P. Balk, Adam G. Sowalsky et al. · 2021 · JCO Precision Oncology
Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer
Fan, Huihui, Li, Jinze, Manuel, Astrid M., Zhao, Zhongming · 2023 · Molecular Therapy - Nucleic Acids
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer
Moritz Hommerding, Oliver Hommerding, Marit Bernhardt, Tobias Kreft, Christine Sanders, Verena Tischler, Patrick Basitta, Natalie Pelusi, Anna‐Lena Wulf, Carsten‐Henning Ohlmann et al. · 2024 · World Journal of Urology
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages
Martino Pedrani, Jessica Barizzi, Giuseppe Salfi, Alessandro Nepote, Irene Testi, Sara Merler, Luís Castelo-Branco, Ricardo Pereira Mestre, Fabio Turco, Luigi Tortola et al. · 2025 · International Journal of Molecular Sciences
Identification of Key Gene Signatures Associated With Bone Metastasis in Castration-Resistant Prostate Cancer Using Co-Expression Analysis
Zhongxiang Yu, Hanlin Zou, Huihao Wang, Qi Li, Dong Su Yu · 2021 · Frontiers in Oncology
Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy
Max Christenson, Chung Seog Song, Yaguang Liu, Bandana Chatterjee · 2022 · Cancers
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Justin H. Hwang, Xiaolei Shi, Andrew Elliott, Taylor E. Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E. Bergom, Abderrahman Day, Shihab Ahmed et al. · 2023 · Clinical Cancer Research
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Pradeep S. Chauhan, Irfan Alahi, Savar D. Sinha, Elisa Marie Ledet, Ryan Mueller, Jessica Linford, Alexander L. Shiang, Jace B. Webster, Lilli J. Greiner, Breanna Yang et al. · 2024 · Clinical Cancer Research
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer
Xiaolin Zhu, Tatyanah Farsh, Daniël J. Vis, Ivan Pak Lok Yu, Haolong Li, Tianyi Liu, Martin Sjöström, Raunak Shrestha, Jeroen Kneppers, Tesa Severson et al. · 2024 · Journal of Clinical Investigation
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer
Larysa Poluben, Mannan Nouri, Jiaqian Liang, Shaoyong Chen, Andreas S. Varkaris, Betul Ersoy-Fazlioglu, Olga S. Voznesensky, Irene I. Lee, Xintao Qiu, Laura Cato et al. · 2024 · Cell Reports
Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer
Meijun Du, Chiang‐Ching Huang, Winston W. Tan, Manish Kohli, Liang Wang · 2020 · Cancers
The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials
Mingyue Xia, Zhigang Guo, Zhigang Hu · 2021 · Biomolecules
Clinical reliability of genomic data obtained from spinal metastatic tumor samples
Ori Barzilai, Axel Martin, Anne S Reiner, Ilya Laufer, Adam M. Schmitt, Mark H Bilsky · 2022 · Neuro-Oncology
Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment
J.-H. Lee, Yun‐Hee Kim, Cheolmin Matthew Lee, Seong Soo Jeon, H.K. Seo, Jong Won Lee, Jungmin Choi, Minyong Kang, Eunjee Kim, Kunyoo Shin · 2025 · PLoS Genetics
Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer
Furong Huang, Kexin Li, Jeffrey W. Shevach, Qianben Wang · 2025 · Journal of the National Cancer Center
Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7
Haojie Chen, Jia Luo, Shaojun Chen, Bowen Shi, Xiaocui Zheng, Haiying Ji, Xiaoqian Zhang, Yujia Yin, Kun Du, Jie Ding et al. · 2022 · Cell Death Discovery
Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer
Tianyi Zhou, Qin Fu Feng · 2022 · Frontiers in Medicine
PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
Ciara S. McNevin, Karen Anne Cadoo, Anne‐Marie Baird, Stephen P. Finn, Ray McDermott · 2022 · Cancers
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
Belén Congregado Ruiz, Ines RIVERO BELENCHON, Guillermo Lendinez Cano, Rafael Antonio Medina López · 2023 · Biomedicines
Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells
Ivana Steiner, Teresita del N.J. Flores-Téllez, Renaud Mével, Amin Ali, Pengbo Wang, Pietá Schofield, Caron Behan, Nicholas Forsythe, Garry Ashton, Cathy Taylor et al. · 2023 · Cell Reports
Genomics and Artificial Intelligence
Elyssa Y. Wong, Timothy N. Chu, Seyedeh‐Sanam Ladi‐Seyedian · 2023 · Urologic Clinics of North America
The yin and yang of chromosomal instability in prostate cancer
Marc Carceles‐Cordon, Jacob J. Orme, Josep M. Domingo Domenech, Verónica Rodríguez-Bravo · 2024 · Nature Reviews Urology
N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis
Xuan Shu, Jiahe Yi, Jiangfeng Li, Yufan Ying, Yijie Tang, Ziyan Chen, Jiaming Wang, Fenghao Zhang, Dingheng Lu, Yuqing Wu et al. · 2024 · Cellular Signalling
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer
Yang Yang, Michelle L. Badura, Patrick C. O’Leary, Henry M. Delavan, Troy M. Robinson, Emily A. Egusa, Xiaoming Zhong, Jason T. Swinderman, Haolong Li, Meng Zhang et al. · 2024 · Nature Cancer
Acquired resistance to molecularly targeted therapies for cancer
Nolan M. Stubbs, Tyler J. Roady, Maximilian P. Schwermann, Elias O.U. Eteshola, William MacDonald, Connor Purcell, Dinara Ryspayeva, Nataliia Verovkina, Vida Tajiknia, Maryam Ghandali et al. · 2025 · Cancer Drug Resistance
Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer
William S. Chen, Eric Li-Len Feng, Rahul Raj Aggarwal, Adam Foye, Tomasz M. Beer, Joshi J. Alumkal, Martin Edwin Gleave, Kim N. Chi, Robert Evan Reiter, Matthew B. Rettig et al. · 2019 · Prostate Cancer and Prostatic Diseases
Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample
Yeeun Shim, Jong Soo Lee, Ji-Eun Seo, Cheol Keun Park, Saeam Shin, Hyun Ho Han, Seung‐Tae Lee, Jong Rak Choi, Byung Ha Chung, Young Deuk Choi · 2022 · Cancer Cell International
A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide
María Piedad Fernández-Pérez, Enrique Pérez, Teresa Alonso‐Gordoa, Vicenza Conteduca, Albert Font Pous, Sergio Vázquez‐Estévez, Aranzazu González del Alba, Daniel Wetterskog, Emmanuel S. Antonarakis, Begoña Mellado et al. · 2022 · The Prostate
Novel Insights into the Role of the Antioxidants in Prostate Pathology
Vittoria Rago, Silvia Di Agostino · 2023 · Antioxidants
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer
Mark L. Daniel, Todd Philip Knutson, Jamie M. Sperger, Yingming Li, Anupama Singh, Charlotte N. Stahlfeld, Courtney N. Passow, Benjamin Auch, Joshua Michael Lang, Scott M. Dehm · 2021 · Endocrine Related Cancer
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
A. M. Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, Anuradha Jayaram, Stephen Q. Wong, Scott Williams, Anupama Pasam, Anna Trigos, Blanca Trujillo, Emily Grist et al. · 2023 · Nature Communications
Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance
Yiming Wan, Quanhua Mu, Rafał Krzysztoń, Joseph Cohen, Damiano Coraci, Christopher Helenek, Christopher Tompkins, Annie J. Lin, Kevin S. Farquhar, Erin Cross et al. · 2023 · Proceedings of the National Academy of Sciences
Integrating PARP Inhibitors in mCRPC Therapy: Current Strategies and Emerging Trends
Bicky Thapa, Navonil De Sarkar, Subhajit Giri, Komal Sharma, Mingee Kim, Deepak Kilari · 2024 · Cancer Management and Research
Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets
Jun Jiang, Donghui Han, Jiawei Wang, Weihong Wen, Rui Zhang, Weijun Qin · 2024 · MedComm
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
Petr Smirnov, Moritz Jakob Przybilla, Milena Simovic-Lorenz, R. Gonzalo Parra, Hana Sušak, Manasi Ratnaparkhe, John Wong, Verena Körber, Jan‐Philipp Mallm, George Philippos et al. · 2024 · Nature Communications
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer
Martine P. Roudier, Roman Gulati, Erolcan Sayar, Radhika A. Patel, Micah Tratt, Helen Richards, Paloma Cejas, Miguel Muñoz Gomez, Xintao Qiu, Yingtian Xie et al. · 2025 · Journal of Clinical Investigation
NUAK family kinase 2 is a novel therapeutic target for prostate cancer
Weiwei Fu, Megan T. Zhao, Lucy M. Driver, Amelia U. Schirmer, Qi Yin, Sungyong You, Stephen J. Freedland, John DiGiovanni, David Harold Drewry, Everardo Macias · 2021 · Molecular Carcinogenesis
Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer
Arielle Shkedi, Isabelle R. Taylor, Frank Echtenkamp, Poornima Ramkumar, Mohamed Alshalalfa, Génesis M. Rivera-Márquez, Michael A. Moses, Hao Shao, Robert Jeffrey Karnes, Len Neckers et al. · 2022 · Cell chemical biology
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer
Xiaobo Wu, Xingbo Long, Chenkai Ma, Yin Celeste Cheuk, Mengbo Hu, Jimeng Hu, Haowen Jiang · 2022 · International Journal of Molecular Sciences
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes
Elie J. Ritch, Cameron Herberts, Evan W. Warner, Sarah W.S. Ng, Edmond M. Kwan, Jack V. W. Bacon, Cecily Q. Bernales, Elena Schönlau, Nicolette M. Fonseca, Veda N. Giri et al. · 2023 · npj Precision Oncology
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone
Evelyne Tassone, Vivian Bradaschia-Corrêa, Xiaozhong Xiong, Ana Sastre-Perona, Anne Marie Josephson, Alireza Khodadadi‐Jamayran, Jonathan Melamed, Lei Bu, David J. Kahler, Liliana Ossowski et al. · 2019 · Oncogene
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
Vipul Bhatia, Bushra Ateeq · 2019 · Trends in Molecular Medicine
Cancer transcriptomic profiling from rapidly enriched circulating tumor cells
Gareth J. Morrison, Alexander T. Cunha, Nita Jojo, Yucheng Xu, Yili Xu, Eric Kwok, Peggy S. Robinson, Tanya Barauskas Dorff, David I. Quinn, John David Carpten et al. · 2020 · International Journal of Cancer
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer
Xiangnan Guan, Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert Evan Reiter, Matthew B. Rettig, Christopher P. Evans, Primo N. Lara, Martin Edwin Gleave, Tomasz M. Beer et al. · 2020 · Clinical Cancer Research
Searching thousands of genomes to classify somatic and novel structural variants using STIX
Murad Chowdhury, Brent S. Pedersen, Fritz Joachim Sedlazeck, Aaron R. Quinlan, Ryan M. Layer · 2022 · Nature Methods
Evolution of structural rearrangements in prostate cancer intracranial metastases
Francesca Khani, William F. Hooper, Xiaofei Wang, Timothy R. Chu, Minita J. Shah, Lara Heermans Winterkorn, Michael Sigouros, Vincenza Conteduca, David J. Pisapia, Sara Elizabeth Wobker et al. · 2023 · npj Precision Oncology
Androgen receptor and estrogen receptor variants in prostate and breast cancers
José C. Valentín López, Carol Ann Lange, Scott M. Dehm · 2024 · The Journal of Steroid Biochemistry and Molecular Biology
Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities
Umer Ejaz, Zhen Dou, Phil Y. Yao, Zhikai Wang, Xing Liu, Xuebiao Yao · 2024 · Journal of Molecular Cell Biology
PROX1 is an early driver of lineage plasticity in prostate cancer
Zhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang, Chao Zhang, Diana Lisbeth Flores, Eva S. Rodansky, Olivia A Swaim et al. · 2025 · Journal of Clinical Investigation
From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.
Chuan Yu, Kevin M. Hu, Daniel Nguyen, Zhu A. Wang · 2019 · PubMed Central
A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways
Aoyu Fan, Yunyan Zhang, Jiangting Cheng, Yunpeng Li, Wei Chen · 2022 · Frontiers in Oncology
The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis
Megan Crumbaker, Eva K.F. Chan, Tingting Gong, Niall M. Corcoran, Weerachai Jaratlerdsiri, Ruth J. Lyons, Anne‐Maree Haynes, Anna Kulidjian, Anton M.F. Kalsbeek, Desiree C. Petersen et al. · 2020 · Cancers
Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer
Sukanya Panja, Sarra M. Rahem, Cassandra Chu, Antonina Mitrofanova · 2020 · Current Genomics
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
Rebeca Lozano, Elena Castro, Fernando López‐Campos, Heather Thorne, M. Backhaus, Isabel M. Aragón, Ylenia Cendón, Ana Gutiérrez-Pecharromán, Daniela Correia Salles, Nuria Romero-Laorden et al. · 2023 · European Journal of Cancer
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis
Carlos S. Moreno, Cynthia L. Winham, Mehrdad Alemozaffar A, Emma R. Klein, Ismaheel O. Lawal, Olayinka A. Abiodun-Ojo, Dattatraya Hari Patil, Benjamin G. Barwick, Yijian Huang, David M. Schuster et al. · 2023 · Cancers
FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer
Oluwademilade Dairo, Lia DePaula Oliveira, Ethan D. Schaffer, Thiago Vidotto, Adrianna Amaral de Aragao Mendes, Jiayun Lu, Sophie Vo Huynh, Jessica L Hicks, Adam G. Sowalsky, Angelo Michael De Marzo et al. · 2023 · Cancer Research Communications
Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate
Xuanrong Chen, Michael A. Augello, Deli Liu, Kevin Lin, Alex Hakansson, Martin Sjöström, Francesca Khani, Lesa Dayal Deonarine, Yang Liu, Jaida Travascio-Green et al. · 2024 · Nature Communications
CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer
Rachel R. Xiang, Shin-Ai Lee, Caroline F. Tyndall, Anusha R. Bhatia, JuanJuan Yin, Cassandra Singler, Benjamin J. Hauk, Matthew P. Kipp, David Yoshio Takeda · 2025 · Cell Reports
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer
Tesa Severson, Emma Minnee, Yanyun Zhu, Karianne G. Schuurman, Holly M. Nguyen, Lisha G. Brown, Sini Hakkola, Renée X. de Menezes, Sebastian Gregoricchio, Yongsoo Kim et al. · 2025 · Cell Reports Medicine
Germline and Somatic Defects in DNA Repair Pathways in Prostate Cancer
Sara Arce‐Gallego, Alejandro Athie, Colin C. Pritchard, Joaquı́n Mateo · 2019 · Advances in experimental medicine and biology
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer
Lisanne Mout, Martin E. van Royen, Corrina de Ridder, Debra C. Stuurman, Wesley S. van de Geer, Rute B. Marques, Stefan A.J. Buck, Pim J. French, Harmen J.G. van de Werken, Ron H.J. Mathijssen et al. · 2021 · EBioMedicine
Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Cristina Maranto, Lavannya Sabharwal, Vindhya Udhane, Samuel P. Pitzen, Braedan M. McCluskey, Songyan Qi, Christine L. O’Connor, Savita Devi, Scott C. Johnson, Kenneth M. Jacobsohn et al. · 2024 · Science Advances
Prostate Cancer Genomic Subtypes
Michael E. Fraser, Alexandre Rouette · 2019 · Advances in experimental medicine and biology
RGS2 is prognostic for development of castration resistance and cancer‐specific survival in castration‐resistant prostate cancer
Anna Linder, Karin Larsson, Karin Welén, Jan‐Erik Damber · 2020 · The Prostate
The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer
Liuxun Li, Jiangli Xu · 2022 · Clinical & Translational Oncology
Single cell multi-omics analysis of chromothriptic medulloblastoma highlights genomic and transcriptomic consequences of genome instability
Rodrigo Parra, Moritz Jakob Przybilla, Milena Simovic-Lorenz, Hana Sušak, Manasi Ratnaparkhe, John KL Wong, Verena Körber, Jan‐Philipp Mallm, Martin Sill, Thorsten Kolb et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Li, Haolong, Melnyk, James E., Fu, Becky Xu Hua, Shrestha, Raunak, Zhang, Meng, Sjöström, Martin, Feng, Siyu, Anderson, Jasmine A., Han, Wanting, Chesner, Lisa N. et al. · 2025 · Nature Genetics
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond
Alice Bernard‐Tessier, Natacha Naoun, Solenn Barraud, Ronan Flippot, Cédric Pobel, Macarena Rey, Capucine Baldini, Christophe Massard, Anna Patrikidou, Alina Cristina Fuerea et al. · 2025 · Therapeutic Advances in Medical Oncology
Joint analysis of WES and RNA‐Seq identify signature genes related to metastasis in prostate cancer
Chongjun Xiang, Yue Li, Wenting Wang, Huiying Tao, Ning Liang, Shuang Wu, Tianxi Yu, Xin Cui, Yaqi Xie, Hongwei Zuo et al. · 2023 · Journal of Cellular and Molecular Medicine
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
Peter H. J. Slootbeek, Sofie H. Tolmeijer, Niven Mehra, Jack A. Schalken · 2023 · Critical Reviews in Clinical Laboratory Sciences